Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across haematology (coagulation disorders), immunotherapy (immune disorders) and critical care therapeutic areas. It sources majority of plasma from company-owned donation centers. Octapharma owns plasma donation centers in the USA and in Germany, and owns six state-of-the-art production facilities in Austria, Germany, France, Mexico and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage and distribution. Octapharma is headquartered in Lachen, Switzerland. Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized... Research Beam Model: Research Beam Product ID: 1916409 250 USD New
Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 23
  • Publisher : GlobalData
 
 
 
Summary

Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across haematology (coagulation disorders), immunotherapy (immune disorders) and critical care therapeutic areas. It sources majority of plasma from company-owned donation centers. Octapharma owns plasma donation centers in the USA and in Germany, and owns six state-of-the-art production facilities in Austria, Germany, France, Mexico and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage and distribution. Octapharma is headquartered in Lachen, Switzerland.

Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Octapharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Licensing Agreements 10
Hikma Pharma Enters into Licensing Agreement with Octapharma 10
Octapharma Enters into Licensing Agreement with Glycotope 11
Equity Offering 12
Glycotope to Raise USD90 Million in Private Placement of Shares 12
Octapharma AG - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 01, 2017: Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million 19
Mar 08, 2016: Octapharma Group publishes 2015 annual results reporting revenue of €1.5 billion and operating income of €351 million 20
Product News 21
Jan 26, 2017: Octapharma USA Launches Co-Pay Assistance Program for Patients Receiving Octagam 5% and Octagam 10% 21
Other Significant Developments 22
Oct 17, 2016: Octapharma Selects Cardinal Health as Authorized Distributor for Product Portfolio in Puerto Rico 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Octapharma AG, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Octapharma AG, Deals By Therapy Area, 2011 to YTD 2017 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Hikma Pharma Enters into Licensing Agreement with Octapharma 10
Octapharma Enters into Licensing Agreement with Glycotope 11
Glycotope to Raise USD90 Million in Private Placement of Shares 12
Octapharma AG, Key Competitors 14
Octapharma AG, Key Employees 15
Octapharma AG, Other Locations 16
Octapharma AG, Subsidiaries 16List of Figures
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter